Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
although it's my first time in labu. pretty sure they did a few reverse split before due to the decay.
quite sad to see amrn going back to low 1s. i remember the last time it went this low was after the anchor adcom disaster.
In that case why would anyone want to swing amrn. Labu will be a better choice.
I bought both on Friday. Amrn will be a mid/long term
hold for me.
Volume too low. A 20k shares sell could bring it down 5 cents.
i don't expect any news yet. Finding a partner usually takes 6 months
or more. Would love to be wrong.
not really. see those investor who bought the offering at much higher price the previous round. 50% losses.
QOL medical which did the filing to purchase 40 millions shares more and Qol meds which is owned by nautic are not the same company.
a offer was make by the website creator but no one seems interested.
A lot forgot pps is in the $2.30s just few months ago. With the recent coordinating bear attack it's still up 350% at $13.50.
something i found in twitter. interesting comment by greenday (he's quite a bull for amrn)
twitter link here
greater epa lvl in evolve trial compared to anchor trial.
Imo it's not only azn. Since 09/24 u can see Matthew herper harping on the mo issue. Lots of fake handles in Twitter with hashtag #amrnfraud etc. Af and Matt harping managed to get those md most critical to reduce it on record after a very short time frame since aha reduce it results are out. See how they managed to drive down share price till $13.50 with all the above uncertainties and how the pps landed very near to Max pain.
Options expiry on the 16th Nov played a big part and for those big shorts to cover.
Now shorts agenda achieved and most of those fake handles are gone.
In the near future. Amarin will be 30% of Baker brothers portfolio. The biggest win they ever have.
so in a way fda was right and wrong at the same time
Sold some 11/16 $22.50 puts and use the proceeds to buy 12/21 calls. Loaded to the gills.
Somehow I feel the market is still underestimating what vascepa can do. Kiwi who is so sceptical of vascepa the past few years (but read this board) now understand it but the cardiologist he's been in contact is still sceptical.
I believe lots of sell side analyst got these cardiologist opinion that's why they got such a "cowish" target.
So my target is
25 by 9th
18 if so so on 12th
45 if CV death is stat sig
60 for the 1st offer of bo e.o.y
When I registered for a account to trade in the u.s market. Have to sign a w-8ben form stating I am not living in u.s nor have any businesses in the u.s. A trade agreement of some sort. Any trade long or short term(even long/short for 2 mins) is not subjected to taxes.
Although it's all I have compared to what many owned on this board it's not much. My situation is same as ddrc(if I get his board name right?) Lots of bad trade and debt after 2013 adcom (raf u r lucky to know amrn after that, So stop being such a jerk) tring to accumulate more amrn the past few years.
I Do think Amarin is worth much more than current price. Just trying to cover all areas bulls or bears alike.
Living in singapre so no tax problem like many here but being a bad trader is much worse.
It's been some time u argued against your position since u went net long in amrn. Anything changes? For real, now I would love to hear your opinion about what could go wrong moving forward.
"we are in the right"
"Tomorrow will be a better day"
JZ devastated that day.
I remembered the time when staccani was advocating pps in the range of $150 in 2014-2015 when amrn is trading $1 ish and I blocked him/her. (Apologize for that.)
Still hard for me to envision a share price above $100 for me. Just a wild guess, 1st offering price will be $60 or $23 billion.
Wondering it as well. Why did azn spend a few hundred millions to do a outcome trial when they are not sure they can get thru vascepa patent. Did they find the very highly high trig market too small that's why they didn't fight it or they are sure that they can get thru the patent that's why they spend so much for outcome trial.
BB I do read all the posts before anchor trial results. In the perfect world. Weekly prescription should be up by 10k by now. Since many opinion leader has been commenting on medscape etc but it has not even with a very stunning 25% rrr(even if mainly is ua and revascularization). Potential is extremely huge for vascepa. Just the valuation for many here is too out of this world.
That being said.even though he always give his opinion in a funny way I do find elf valuation makes sense. Hopefully jl won't be in to chastise me
Seen too many bio stocks forum calculatiing patient population % penetration rate over the years. It's
very easy to calculate with a pen and a piece of paper. Real world is something totally different.
I have a question. Does lipitor , crestor or any other statin hit the endpoint of CV death in the pasts trial?
Isn't max $30 plus what most here has predicted when they guess the rrr is 30%+ before 24th sept?
Now that results is 25%+. Suddenly consensus here is 50 to 200 or more.
Before and after 24th Sept. Have the guesstimate of annual revenue really change that much even though rrr is lower then what most have predicted.
Trying to figure out the change of mindset since results is lower than what most have predicted but expectations for pps has tripled.
U mean most of the board members have been lowballing ourselves during the guesstimate contest that hdg held?
I remembered the 10000 puts a day before the adcom briefing doc was out. Fda is full of leaks. Submission also need to make a lot of preparation. It's not like just submitting the full data. It will take a few months.
Prior reduce-it results half of the board members have predicted/guesstimate a rrr upwards of 25% . At that time iirc market cap prediction[img] was like max in the $10 billion range if results are good. Now that results are out and it is 25%+ but pps prediction has gone up from 40 till 200. I wonder what has changed from % of rrr to market cap since many have predicted 25%+ prior to actual result.
JL did mentioned that this will be like a beverage company like coca cola if results are good the past few years though.
note: i am not a short. i predicted around 28% in HD contest before 1st interim.
John is the main organiser but the website was designed and maintained by another board member. I vaguely remember u donated some money for the setup too.
If fda did not rescinded the anchor spa in 2013. Around 30k (1 million patient taking vascepa) mace event which include death would have been prevented.
I remember the time when epadi member writing letters to woodcork to urge her to overturn the decision of rescinding the spa. No patient will be harmed if they approve anchor and if reduce it turn out positive many lives would be saved.
The mistakes that fda made on 2013 killed a lot of people if 10th Nov vascepa proof that it reduces morality.
Can't remember which board member it is but I am very thankful for designing and maintaining (using his/her own money) the epadi website all these years. A very sincere thank you!
Sold out my position today. Not because I want to protect my profit but because of greed. I expect a pullback in the next week or so and I can buy back more shares before aha and beyond. Even with insider selling it's still green today. Looking very strong. I do understand that what I am doing might be a very bad move. Might lose out another 100% gain from current level if there's a whiff of buyout rumors or positive itc ruling.
Open a bottle of red wine. Silently celebrating with gf. Thanks to all on board for the science. Devastated after adcom but now made whole again :)
Baker brothers did do a purchase at the 1.50s range thru a private placement. After that pps increased till $3.30 after news of b.b is the buyer of the private placement.
this reminds me of the fake 'emeritus' where jl is being harsh on him.
current poster seems sincere to me though and i do enjoyed his view. dont stop posting studythosestocks!
from what i understand from the reply. the 'coincident' seems to mean there will be additional info beside the usual stuff that is in a 10k. anyone read the same?
Thats very good dd. tks for sharing.
also the $2 million buy from one of the director near company cash per share level.
high probability for good profit continuing holding this.
if manage to close above 1.15 50d sma its still good
Would like to believe that the trial most likely will run to completion
as what management has been saying all along but if that is highly probable
dont think they will add a 2nd interim. My prediction as follows,
stop / 20th March / 28th June / 22.50%
Don't u find a burn rate of 9 million per q is awfully high for a company that don't have much trial going on. 1 P1 for imo-2125 and 2 p2 trial for imo-8400. Total patient should be less than 100. The rest of the pipeline is near preclinical stage.
Company is spending 100k per day.
Might be the notes that got converted recently. Outstanding shares now has increased to 269 million from ard 200 million.
Form 4 for jt and kennedy.
Should be rsu and both sold around half of it.
Is it still possible that p.e efficacy is north of 30? but DMC opted for continuing coz s.e is not robust enough? Has there been historic reference that we can inferred to?
Unless the placebo rate is much lower than what most on board predicted and all the science I have been reading so far.
With 4.83? combine rate. my thought is that a stop is highly likely @ 60? interim..
you can take ref from espr. fda told them they will not accept ldl-c as a surrogate for approval and they must do a outcome trial. Even if they have a spa and a p3 which is successful. most probably fda will tell them the same thing.